Andere Sprachen Evotec SE Deutsche Boerse AG

Aktien

566480

DE0005664809

EVT

Realtime-Estimate Tradegate Andere Börsenplätze 21:51:24 13.06.2024			% 5 Tage	% 1. Jan.
8,56 ^EUR	-4,62 %		-2,64 %	-59,38 %

12.06.	Sehr fest nach US-Inflationsdaten - Autosektor im Blick	DJ
12.06.	Günstige US-Inflationsdaten treiben Börsen und Euro	DJ

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Evotec profitieren verhalten von Forschungszahlung	12.06.
Evotec to Receive $20 Million Under Neuroscience Partnership with Bristol Myers Squibb	12.06.
Evotec Gets $20 Million Milestone Payment in Neurodegenerative Disease Collaboration With Bristol Myers Squibb	12.06.
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb	12.06.
Evotec announces progress in neuroscience collaboration with Bristol Myers Squibb	12.06.
Evotec : Presence and Voting Results AGM 2024 229.115 KB	11.06.
Evotec SE: Results of the Annual General Meeting 2024	10.06.
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	04.06.
Evotec : Aurobac Therapeutics presents its R&D strategy & pipeline and announces new development program with Boehringer Ingelheim	03.06.
Evotec : and QIAGEN enter software collaboration for enhanced multi-omics data insights	03.06.
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	30.05.
Evotec Partners With French Institutions, Company to Research Obesity	30.05.
Evotec Joins Collaboration to Identify New Therapies for Obesity, Metabolic Diseases	30.05.
Evotec, Inserm, Lille Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases	30.05.
Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases	30.05.
Evotec : Update of the Declaration of Conformity with the German Corporate Governance Code for the Year 2023 (May 2024) 127.622 KB	29.05.
Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington's disease	29.05.
Evotec Extends Drug Discovery Collaboration With CHDI Foundation for Huntington's Disease	28.05.
Evotec, CHDI Foundation Extend 20-year Partnership for Huntington's Disease Treatments	28.05.
Evotec and CHDI Foundation Extend Strategic Drug Discovery Collaboration in Huntington?s Disease	28.05.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Evotec SE Deutsche Boerse AG

Aktien

566480

DE0005664809

EVT

Andere Sprachen

Filter